OTCMKTS:GNWSF StageZero Life Sciences (GNWSF) Stock Price, News & Analysis $0.15 0.00 (0.00%) (As of 09/27/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsHeadlinesSEC Filings Get StageZero Life Sciences alerts: Email Address About StageZero Life Sciences Stock (OTCMKTS:GNWSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GNWSF alerts:Sign Up Key Stats Today's Range$0.01▼$0.2050-Day Range$0.00▼$0.1552-Week Range$0.00▼$1.27Volume1 shsAverage Volume26,719 shsMarket Capitalization$9.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewStageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.Read More… How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure (Ad)The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Click here now to learn how you can position yourself for potentially massive gains. Receive GNWSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GNWSF Stock News HeadlinesStageZero Life Sciences (OTCMKTS:GNWSF) Trading Up 88.5%September 25 at 8:36 PM | americanbankingnews.comHow Boy Meets World’s Ben Savage Views Maitland Ward's Porn CareerSeptember 25 at 5:26 PM | msn.comThe True Potential for Civil War…Radical leftists mobilizing illegal immigrants, violence and looting, even marital law. 43% of respondents, for example, in a recent survey said they believe a civil war is “likely” in the next decade.September 27, 2024 | Paradigm Press (Ad)Chicago Beat: NanoGraf expands footprint, what's next for life sciences in ChicagoSeptember 25 at 5:26 PM | bizjournals.comNYC High Line hosts science fair to teach public about climate changeSeptember 21, 2024 | yahoo.comScientists Have Uncovered a 3rd State of Life, Which Starts After Cell DeathSeptember 20, 2024 | msn.comArchaeologists conduct first 'space excavation' on ISS and discover surprising quirks of zero-G lifeAugust 12, 2024 | msn.comThe wait is almost over for GCSC’s new Natural Sciences buildingJuly 26, 2024 | msn.comSee More Headlines GNWSF Stock Analysis - Frequently Asked Questions How have GNWSF shares performed this year? StageZero Life Sciences' stock was trading at $0.0294 at the beginning of 2024. Since then, GNWSF shares have increased by 412.9% and is now trading at $0.1508. View the best growth stocks for 2024 here. How do I buy shares of StageZero Life Sciences? Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolOTCMKTS:GNWSF CUSIPN/A CIK1454263 Webwww.stagezerolifesciences.com Phone905-209-2030FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,860,000.00 Net Margins-200.26% Pretax MarginN/A Return on EquityN/A Return on Assets-165.13% Debt Debt-to-Equity RatioN/A Current Ratio1.15 Quick Ratio1.08 Sales & Book Value Annual Sales$4.15 million Price / Sales2.29 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-7.54Miscellaneous Outstanding Shares62,995,000Free FloatN/AMarket Cap$9.50 million OptionableNot Optionable Beta0.28 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (OTCMKTS:GNWSF) was last updated on 9/27/2024 by MarketBeat.com Staff From Our Partners10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredPrepare for an election day stock surpriseDuring his 50 years on Wall Street, legendary stockpicker Marc Chaikin traded through 13 presidential election...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.